Back

Prediction and cumulative incidence of in-hospital bleeding among acutely ill medical patients receiving pharmacologic VTE prophylaxis based on the IMPROVE-BRS: a retrospective single-center cohort

29 August 2026 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Clinico-metabolic phenotyping and heart disease (2) Scores ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Josefino Iii Catangui

Manila (Philippines)

6 More presentations in this session

Presentation thumbnail
Clinico-metabolic phenotyping predicts long-term mortality in at-risk and pre-clinical heart failure: a machine learning analysis
Miss A. Mavromanoli (Mainz, DE)
Abstract
Presentation thumbnail
Understanding and predicting CVD in Singapore: socioeconomic determinants and a non-lab risk score across two cohorts
Professor D. Hausenloy (Singapore, SG)
Abstract
Presentation thumbnail
Primary care detection reveals substantial cumulative LDL-C exposure in underrecognized heterozygous FH
Doctor H. Leskaroska (Skopje, MK)
Abstract
Presentation thumbnail
The clinical value of estimated small dense LDL in primary and secondary prevention
Doctor D. Delialis (Athens, GR)
Abstract
Presentation thumbnail
Incremental value of ADMA beyond classical risk factors for cardiometabolic risk prediction in ischemic heart disease
Doctor S. Akhmedov (Tashkent, UZ)
Abstract

Access the full session

Session thumbnail
Clinico-metabolic phenotyping and heart disease (2)

The Event

Event poster

ESC Congress 2026

29 August 2026 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Prediction of major bleeding in patients receiving DOACs for venous thromboembolism: a prospective cohort study.
31 August 2019
thumbnail
Congress Presentation
Impact of heparin induced thrombocytopenia (HIT) in outcomes of patients admitted to the hospital with heart failure- a national perspective in United States
29 June 2021
thumbnail
Congress Presentation
Validation of the European SCORE2 algorithm in four European and non-European cohort studies with contrasting populations
3 April 2025
thumbnail
Congress Presentation
HI-PRO: Apixaban for Extended Treatment of Provoked Venous Thromboembolism
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources